- Book学术

发布求助

文献互助智能选刊最新文献

IF 58.7 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Nature Medicine Pub Date : 2025-03-26 DOI:10.1038/s41591-025-03587-w

Anna M. Anderson, Rachelle A. Martin, Willyanne DeCormier Plosky, Lieketseng Ned, Bonnielin K. Swenor, Jodie Bailie, Kaaren Mathias, Jasjot K. Maggo, Mildred A. Omino, Amy M. Russell, Anna M. M. Lawson, Anna E. Brown, Barbara E. Bierer, Sameed Shariq, Mrisho Mwifadhi, Katherine H. O. Deane, Sharad Philip, Victoria Shepherd, Nicola E. Walsh, Gretl A. McHugh

引用次数: 0

摘要

尽管残疾人拥有巨大的优势，但他们在健康方面也面临着巨大的不平等，因此，健康研究对他们的服务仍然不足；要解决这个问题，就必须采取横跨所有研究领域的多层次行动。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

A global call to action for disability inclusion in health research

查看原文本刊更多论文

A global call to action for disability inclusion in health research

Despite bringing great strengths and facing substantial health inequities, disabled people remain underserved by health research; addressing this requires multi-level actions spanning all areas of research.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Medicine 医学-生化与分子生物学

CiteScore

100.90

自引率

0.70%

发文量

525

审稿时长

1 months

期刊介绍： Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.